NC
PASG icon

NinePointTwo Capital’s Passage Bio PASG Stock Holding History

NinePointTwo Capital’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-806
Closed -$38K – 217
2022
Q2 		$38K Hold
806
– – 0.01% 194
2022
Q1 		$49K Buy
+806
New +$66.4K 0.01% 214

Other funds holding PASG

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HCM
Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

NinePointTwo Capital's PASG Position: Q3 2022 in Review

NinePointTwo Capital sold out of Passage Bio (PASG) in Q3 2022, closing a stake of 806 shares — an estimated $38K sold.

NinePointTwo Capital first reported a position in PASG in Q1 2022 and held it in 2 quarters. The position peaked at $49K in Q1 2022. 75 funds tracked by Wall St. Rank hold PASG as of Q3 2022.

  • NinePointTwo Capital reported no remaining Passage Bio position as of Q3 2022 after selling out during the quarter.
  • NinePointTwo Capital sold 806 Passage Bio shares in Q3 2022, an estimated $38K.
  • NinePointTwo Capital first reported a position in Passage Bio in Q1 2022 and held it in 2 quarters.
  • NinePointTwo Capital's Passage Bio position peaked at $49K in Q1 2022.
  • 75 funds tracked by Wall St. Rank held Passage Bio as of Q3 2022.

Based on NinePointTwo Capital's 13F filing for Q3 2022, filed 14 Nov 2022.